JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8
Tadahiko Nakagawa(University of Shimane), Tetsuji Takayama(Tokushima University)
Cited by 26
Related Papers
MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma
|Oncotarget|2016|66
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer
|Molecular Cancer Research|2017|62
High antitumor activity of pladienolide B and its derivative in gastric cancer
|Cancer Science|2013|52